Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP569080.RAa9G7qgg_EEk9nuDHZrGZ4mgZbfpSsWwJKkIIAQ9tTt8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP569080.RAa9G7qgg_EEk9nuDHZrGZ4mgZbfpSsWwJKkIIAQ9tTt8130_assertion type Assertion NP569080.RAa9G7qgg_EEk9nuDHZrGZ4mgZbfpSsWwJKkIIAQ9tTt8130_head.
- NP569080.RAa9G7qgg_EEk9nuDHZrGZ4mgZbfpSsWwJKkIIAQ9tTt8130_assertion description "[RASSF1A, E-Cadherin and p16INK4A methylation was documented in 20, 44 and 33% of the cases with p16INK4A significantly associated with metastatic tumours (P=0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP569080.RAa9G7qgg_EEk9nuDHZrGZ4mgZbfpSsWwJKkIIAQ9tTt8130_provenance.
- NP569080.RAa9G7qgg_EEk9nuDHZrGZ4mgZbfpSsWwJKkIIAQ9tTt8130_assertion evidence source_evidence_literature NP569080.RAa9G7qgg_EEk9nuDHZrGZ4mgZbfpSsWwJKkIIAQ9tTt8130_provenance.
- NP569080.RAa9G7qgg_EEk9nuDHZrGZ4mgZbfpSsWwJKkIIAQ9tTt8130_assertion SIO_000772 16969349 NP569080.RAa9G7qgg_EEk9nuDHZrGZ4mgZbfpSsWwJKkIIAQ9tTt8130_provenance.
- NP569080.RAa9G7qgg_EEk9nuDHZrGZ4mgZbfpSsWwJKkIIAQ9tTt8130_assertion wasDerivedFrom befree-2016 NP569080.RAa9G7qgg_EEk9nuDHZrGZ4mgZbfpSsWwJKkIIAQ9tTt8130_provenance.
- NP569080.RAa9G7qgg_EEk9nuDHZrGZ4mgZbfpSsWwJKkIIAQ9tTt8130_assertion wasGeneratedBy ECO_0000203 NP569080.RAa9G7qgg_EEk9nuDHZrGZ4mgZbfpSsWwJKkIIAQ9tTt8130_provenance.